John White, MD
Family Medicine · Richmond, VANPI 1336148923
Payments from drug & device makers
Across 93 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$146
- Sumitomo Pharma America, Inc.$129
- Novo Nordisk$108
- Bayer$107
- Pfizer$102
- Xeris Pharmaceuticals, Inc.$100
- plus $870 from 24 others
What the payments were for
- Food & beverage$1,562100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 8 | $146 |
| Sumitomo Pharma America, Inc. | 6 | $129 |
| Novo Nordisk | 7 | $108 |
| Bayer | 6 | $107 |
| Pfizer | 4 | $102 |
| Xeris Pharmaceuticals, Inc. | 6 | $100 |
| Lilly USA, LLC | 7 | $99 |
| Astellas Pharma US Inc | 5 | $86 |
| AbbVie | 5 | $81 |
| GSK | 4 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Amgen | 3 | $47 |
| Eisai Inc. | 3 | $46 |
| AstraZeneca | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Exact Sciences | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Genentech USA, Inc. | 2 | $26 |
| Lundbeck LLC | 1 | $21 |
| Merck | 1 | $19 |
| Neurelis, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,562 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 60 | $54,515 |
| EliquisApixaban | 15 | $10,226 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $5,826 |
| Diclofenac Sodium | 15 | $2,470 |
| Atorvastatin Calcium | 128 | $890 |
| Gabapentin | 86 | $880 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 11 | $869 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $844 |
| Omeprazole | 61 | $802 |
| Duloxetine Hcl | 26 | $644 |
| Levothyroxine Sodium | 65 | $639 |
| SynthroidLevothyroxine Sodium | 18 | $634 |
| Amlodipine Besylate | 123 | $549 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $545 |
| Rosuvastatin Calcium | 87 | $512 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $108 | $54,51560 claims |
| PfizerEliquis | $102 | $10,22615 claims |
| AbbVieSynthroid | $81 | $63418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,553 family medicine providers in Virginia.
Other family medicine in Richmond
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Banks TurnerRichmond$74K
- James FosterRichmond$27K
- George MaughanRichmond$21K
- Aaron HartmanMidlothian$17.4M
- John ScottGlen Allen$16.7M
- Banu MyneniPortsmouth$12.8M
- Patricia HouserWinchester$3.5M
- Stephan JannachDanville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.